Members

Primary research is on the determinants and impact of health, nutrition and education on human populations. A notable example this work is a 50-year prospective study of Guatemalans exposed to an experimental nutritional supplement in early life to determine the impact of nutrition, education and genetic-environmental impact.
Learn More

Interested in understanding the influence of race and ethnicity in genetics and genomics research. Current project include a study of social and ethical issues associated with minority enrollment in precision medicine research and a study of ethical issues associated with the use of machine learning in precision medicine.
Learn More

Research interest includes understanding the etiology of Atopic dermatitis (AD) a.k.a. eczema by looking at the complex interplay between genetic, immune, and environmental contributors to the condition. Exploring the phynotypic and genetic characteristics of Hispanic/Latino patients with AD compared to non-Hispanic patient with AD
Learn More

An internationally recognized scholar, public intellectual, and social justice advocate, she has written and lectured extensively on race, gender, and class inequities in U.S. institutions and has been a leader in transforming public thinking and policy on reproductive freedom, child welfare, and bioethics. Her authorships include Killing the Black Body: Race, Reproduction, and the Meaning of Liberty; and Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-First Century.
Learn More

Dr. Gaulton oversees the full scope of global heath activities at the Perelman School of Medicine with a mission to improve health equity worldwide through improved awareness and access to care, discovery and outcomes based research, and comprehensive educational programs grounded in partnership.
Learn More

An oncogenomics physician-scientist whose research looks at the somatic and inherited genetics of cancer. Current research include identification of novel breast cancer susceptibility genes, understanding tumor heterogeneity in BRAC1/2 mutation associated cancers, and evaluating the interaction and function of non-canonical BRAF mutations with other MAPK mutations using single cell sequencing.
Learn More

A medical geneticist, whose primary research focus is on the genetic susceptibility to infectious diseases. Dr. Sirugo spent many years as a Research Clinician at the MRC (UK) Unit in The Gambia, West Africa. There he created and directed the first DNA bank in sub-Saharan Africa, funded by the MRC in the year 2000. He participated, as a co-investigator, in the Wellcome–Trust Consortium for genome-wide association studies of tuberculosis and malaria.
Learn More

Dr. Glennis Logsdon is an Assistant Professor of Genetics and a Core Member of the Epigenetics Institute. Her lab uses long-read sequencing technologies and innovative computational methods to build complete, telomere-to-telomere (T2T) sequence assemblies of diverse human genomes to better understand human variation. Her lab is also involved in efforts to build the first human pangenome, which aims to provide a more complete representation of human diversity, improve health equity, and reduce health disparities globally.
Learn More

A neurointensivist and clinical researcher whose area of expertise is in coagulation derangements associated with severe brain injury. A leader in the Neurology Department’s IDARE (Inclusion, Diversity and Anti-Racism Efforts) Committee. She is active in both the American Stroke Association and the Society for Critical Care Medicine, and just completed her tenure on both the NCS BOD and NCS Executive Committee and served as the Board liaison to the Inclusion in Neurocritical Care Committee, the DEI Committee of the Neurocritical Care Society.
Learn More

A researcher specializing in systems-based approaches to building equity in the biomarker translation and clinical genomics. Integrating principals of epidemiology, informatics and clinical genomics, my research focuses on identifying and building solutions to disparities in biomarker research, implementation, utility and access.
Learn More

A surgeon-scientist dedicated to advancing the understanding of the biological pathways and mechanisms most relevant in the etiology, progression, and treatment of heart and vascular disease. His research leverages his clinical vascular surgery experience to inform population scale genomic research. In this, he has focused primarily on disease that he also treats clinically: peripheral artery disease (PAD), venous thromboembolism (VTE), abdominal aortic aneurysm (AAA), and thoracic aortic disease (TAD). Situated within the VA Million Veteran Program and the Penn Medicine BioBank, Dr. Damrauer’s work has significantly advanced our understanding of the genetic architecture of these diseases.
Learn More

My main research interests center on socioeconomic and geographic inequalities, and race/ethnic differences in mortality across the life course and aging and cognitive health. I recently completed a pilot study in Ghana to adapt the Harmonized Cognitive Assessment Protocol (HCAP) for fielding in a low-middle income country in Sub-Saharan Africa funded by the NIA-supported HCAP Network. I am a co-investigator and/or subcontract PI on NIA funded studies on Trajectories of Cognition in Middle Age: Implications for Alzheimer's Disease and Related Dementias in the U.S.; Functional Impairment in Middle-Aged Adults; and Demography of Immigrant Mortality in the United States: Leveraging Novel Census Linkages to Death Records, Earnings Trajectories, and Residential Mobility.
Learn More